Who mentions $VKTX most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $VKTX most — 10 mentions in the past 12 months.

When was $VKTX first mentioned on Surfaced?

The earliest tracked mention of $VKTX in the Surfaced archive was on Aug 19, 2025.

How many voices track $VKTX?

7 FinTwit voices have mentioned $VKTX 29 times in the past 12 months.

What kind of voices mention $VKTX most?

$VKTX is mentioned most by Long Research voices on Surfaced.

$VKTX — FinTwit mentions on Surfaced

Recent mentions

29 mentions

@adamfeuersteinJun 15, 2026 · 9:45 PM

$ABVX $NKTR $VKTX $NTLA

Open on X

@investmentguru_Apr 25, 2026 · 9:27 PM

Big earnings week ahead. Names on deck: $AMKR $CDNS $HOOD $SPOT $GLW $BE $ENPH $AMZN $MSFT $META $GOOGL $QCOM $SOFI $LMND $KLAC $VKTX $VIAV $AAPL $RDDT $RBLX $ZETA $RIVN $SNDK $WDC $ROKU $FSLR $TEAM $AXTI Plenty of market-moving catalysts across AI, tech, fintech, solar, biotech, and consumer. Expect volatility, sharp reactions, and opportunities. Stay selective. Trade the setup, not the hype.

Open on X

@stocksavvyshayApr 25, 2026 · 3:43 PM

THE SUPER BOWL OF EARNINGS IS NEXT WEEK • Monday | $AMKR, $CDNS • Tuesday | $HOOD, $SPOT, $GLW, $BE, $ENPH • Wednesday | $AMZN, $MSFT, $META, $GOOGL, $QCOM, $SOFI, $LMND, $KLAC, $VKTX, $VIAV • Thursday | $AAPL, $RDDT, $RBLX, $ZETA, $RIVN, $SNDK, $WDC, $ROKU, $FSLR, $TEAM, $AXTI

Open on X

@kaizen_investorApr 5, 2026 · 9:15 PM

@b_co_co I’m a fan of $AAOI, $PL, $PLTR and $VKTX. Not a fan of $DUOL.

Open on X

@kaizen_investorApr 3, 2026 · 10:03 PM

I just cracked the CEO-code. - Founder led - PhD in science $PL - Will Marshall Ph.D. in Physics $AAOI - Chih-Hsiang Ph.D in electrical engineering $VKTX - Brian Lian Ph.D in Organic Chemistry $PLTR - Alex Karp Ph.D in Neoclassical Social theory Looks like you just have to look at your favourite industry, look for a CEO with a Ph.D in science and buy the stock. Looks like you can’t miss.

Open on X

@kaizen_investorApr 1, 2026 · 6:05 PM

3 stock I think will bounce back in 2026. 1. $HIMS HIMS is perfectly positioned to capture the new pharma wave. GLP-1 is still the fastest growing TAM outside AI. While the AI TAM is still unclear how it will develop, the GLP-1 wave is quite predictable. HIMS just needs to bring the products to the customer. The more customers they can bring to the platform, the more attractive HIMS will be to peptide producers. At the moment we have 2 GLP-1 producers, $NVO and $LLY. This will increase in the near future. $ROP, $PFE, and $VKTX are all working on their own peptide variant. With recent acquisitions in Europe, HIMS is making sure they are ideally positioned to reach as many customers as possible. The stock was at $70 when the Novo deal collapsed. In the meantime, they made some great acquisitions and started some great initiatives such as HERS and Hims Labs to attract more customers to the platform. I recently bought some extra $HIMS.

Open on X

@acinvestorblogMar 23, 2026 · 10:18 AM

$VKTX HC Wainwright & Co. Reiterates Buy and Maintains $102 Price Target

Open on X

@investmentguru_Mar 20, 2026 · 10:51 AM

Where to concentrate in this market NeoCloud $IREN $CIFR $NBIS Photonics $COHR $LITE $POET $LWLG Chips $NVDA $MU $TSEM Drone + Defence $ONDS $KTOS $RCAT Robotics +Automation $SERV $TSLA $ISRG $PATH Fintech $SOFI $HOOD $GLXY Healthcare + Biotech $HIMS $VKTX $LLY $ABCL AI Infrastructure $PLTR $AMD $GLW $CLS Aerospace $RKLB $ASTS $PL $RDW Energy + renewables $OKLO $VRT $ENPH $TE Quantum $IONQ $RGTI $QUBT

Open on X

@adamfeuersteinMar 14, 2026 · 11:13 AM

@CloisterRes You just made a stronger argument for $VKTX in a single X post than its CEO has ever done in all his conference calls and investor presentations.

Open on X

@stocksavvyshayFeb 24, 2026 · 2:24 PM

@VanquishTrader $NVO needs to spend $15B and just buy out $VKTX already

Open on X

@stocksavvyshayFeb 23, 2026 · 12:41 PM

@PolymarketMoney Hard not to wonder if $NVO should just bite the bullet and make a move on $VKTX at $100+.

Open on X

@adamfeuersteinFeb 4, 2026 · 3:44 PM

@CloisterRes @Biohazard3737 This might sound mean and simplistically stupid, but is it possible the problem is $VKTX CEO Brian Lian? You know the saying, "He could sell ice to eskimos." Brian is the opposite of that. Forget about selling, I don't know if Brian could give away a glass of water to a man dying of thirst. Maybe Viking needs a messaging revamp. Free advice.

Open on X

@adamfeuersteinFeb 4, 2026 · 1:32 PM

@Biohazard3737 Because $VKTX is none of those things?

Open on X

@stocksavvyshayJan 30, 2026 · 2:58 PM

@cdad1121 I've shared multiple updates on $VKTX and $CLPT this year in the growth portfolio community?

Open on X

@investmentguru_Jan 14, 2026 · 6:46 PM

$VKTX nice move today

Open on X

@tradableastroJan 14, 2026 · 1:56 AM

$VKTX Compressing https://t.co/w4v5Mo7gjl

Open on X

@stocksavvyshayJan 5, 2026 · 3:12 PM

@PolymarketMoney $VKTX is my favorite name in this space

Open on X

@investmentguru_Jan 4, 2026 · 1:13 PM

Big Picture | Where the Next Cycle Is Taking Us: Space: The Next Strategic Infrastructure Layer $RKLB, $ASTS, $RDW, $PL Enterprise AI: From Pilots to Profits $PLTR, $SNOW, $NOW Mag 7: Leadership Rotation, Not Extinction $NVDA, $GOOGL, $MSFT, $META, $AAPL, $TSLA, $AMZN Power & Energy: The Real AI Bottleneck $CEG, $EOSE, $OKLO Semiconductors: The Picks-and-Shovels of Every Megatrend $NVDA, $AMD, $AVGO, $ARM Defense & Autonomy: Geopolitics Meets AI $KTOS, $LMT, $RTX, $PLTR, $ONDS Robotics & Automation: Solving the Labor Shortage $TSLA, $SYM, $ISRG, $ABB, $RR AI Infrastructure & Data Centers $NBIS $CIFR $IREN Fintech 2.0: Profitable, Scaled, Embedded $SOFI, $HOOD, $PYPL Healthcare AI & Biotech Platforms $ABCL, $RXRX, $VKTX Uranium & Nuclear Renaissance $OKLO, $SMR, $CCJ, $LEU Battery Tech & Energy Storage $QS, $ENVX, $EOSE, $FLNC, $BE

Open on X

@stocksavvyshayJan 3, 2026 · 2:01 PM

MY TOP 10 GROWTH PORTFOLIO POSITIONS ENTERING 2026 1. $RKLB building the future of space logistics 2. $CLPT providing a navigation platform for neurosurgeons 3. $JMIA scaling e-commerce & logistics across Africa 4. $EOSE building zinc storage built for nonstop compute 5. $ASTS building the communications layer that monetizes space-based connectivity 6. $TMDX expanding organ care through a growth fleet & network effect 7. $VKTX developing oral & injectable GLP-1s for obesity & diabetes 8. $SOFI becoming a full-stack digital bank positioned for a liquidity upcycle 9. $IONQ positioning quantum as the overflow layer once classical compute hits physical limit 10. $IREN building compute at industrial scale

Open on X

@investmentguru_Dec 28, 2025 · 10:33 PM

10 stocks that is buying opportunity in this market, for long term. $NFLX — Streaming Giant Still Printing Cash. Netflix continues to dominate global streaming with expanding margins, ad-tier growth, and pricing power that the market still underestimates. $NVO — Healthcare Titan on a Rare Pullback. Novo Nordisk remains the undisputed leader in diabetes and obesity care, offering long-term compounding at a valuation reset. $VKTX —Asymmetric Biotech Bet Viking Therapeutics offers massive upside optionality in metabolic disease with limited downside relative to its pipeline potential. $PYPL — Turnaround Value in Digital Payments. PayPal trades at depressed valuations despite strong cash flow, buybacks, and a reset strategy focused on profitable growth. $UNH — Defensive Growth at a Discount. UnitedHealth combines scale, cash flow, and healthcare dominance, making it one of the safest long-term buys during uncertainty. $QCOM — Silent Winner of the AI + Connectivity Cycle. Qualcomm’s leadership in wireless, AI-enabled chips, and diversified revenue streams makes it deeply undervalued versus its future earnings power. $NKE — Global Brand Cyclical Reset Nike’s brand strength and global reach position it for a multi-year recovery as inventory and margins normalize. $PATH — Enterprise AI Automation Play. UiPath sits at the intersection of AI and enterprise productivity, with automation demand accelerating across industries. $BULL — Leveraged Bet on Market Momentum. BULL amplifies upside when markets trend higher, making it a tactical weapon for bullish short-term conviction. $OSCR — High-Risk Healthcare Disruptor. Oscar Health is a speculative turnaround where operational execution could unlock significant upside — but patience is required. Not a financial advice

Open on X

@investmentguru_Dec 28, 2025 · 1:07 PM

Big Picture | Where the Next Cycle Is Taking Us: Space: $RKLB, $ASTS, $RDW, $PL Enterprise AI: $PLTR, $SNOW, $MDB, $NOW Mag 7: $NVDA, $GOOGL, $MSFT, $META, $AAPL, $TSLA, $AMZN Power & Energy: $CEG, $OKLO, $BE Semiconductors: $NVDA, $AMD, $AVGO, $ARM Defense & Autonomy: $KTOS, $LMT, $PLTR, $ONDS Robotics & Automation: $TSLA, $SYM, $ISRG, $ABB, $RR AI Infrastructure & Data Centers $NBIS $CIFR $IREN Fintech: $SOFI, $HOOD, $PYPL, $AFRM, Healthcare AI & Biotech Platforms $ABCL, $RXRX, $VKTX Uranium & Nuclear Renaissance $OKLO, $SMR, $BWXT, $LEU Battery Tech & Energy Storage $QS, $EOSE, $FLNC, $BE

Open on X

@kaizen_investorDec 22, 2025 · 9:18 PM

Biotech & Genomics is the 2nd largest growing TAM globally. Despite this potential, the sector remained stagnant in 2025. While capital flooded into AI, pharma was ignored. I expect this to change in 2026. Here are the companies on my watchlist: Metabolic & Weight Loss Leaders • $LLY (Eli Lilly): Obesity, diabetes, and Alzheimer's drugs • $NVO (Novo Nordisk): Global leader in diabetes care • $VKTX (Viking Therapeutics): Potent oral obesity therapies Surgical Robotics & Navigation • $ISRG (Intuitive Surgical): Robotic minimally invasive surgery • $PRCT (Procept BioRobotics): Robotic waterjet prostate surgery • $CLPT (ClearPoint Neuro): Precise navigation for brain surgery Gene Editing Pioneers • $NTLA (Intellia Therapeutics): In-vivo CRISPR gene editing • $BEAM (Beam Therapeutics): Precision genetic base editing • $PRME (Prime Medicine): Precise search-and-replace gene editing Diagnostic & Monitoring Tech • $DXCM (DexCom): Continuous glucose monitoring sensors • $NTRA (Natera): DNA testing for cancer/transplants • $WGS (GeneDx): Genomic diagnostics for rare diseases Specialized Biotech & Organ Care • $VRTX (Vertex): Cystic fibrosis and pain cures • $ARGX (Argenx): Novel autoimmune disease treatments • $TMDX (TransMedics): Living organ transport systems Bio-Infrastructure & Data • $VEEV (Veeva Systems): Cloud software for life sciences • $IQV (IQVIA): Clinical trial data and analytics • $TMO (Thermo Fisher): Scientific equipment and lab services • $DNA (Ginkgo Bioworks): Platform for cell programming Consumer Digital Health • $HIMS (Hims & Hers): Personalized telehealth and prescriptions

Open on X

@adamfeuersteinNov 4, 2025 · 2:33 PM

@A_May_MD $VKTX longs https://t.co/G9KER8QOVM

Open on X

@adamfeuersteinOct 30, 2025 · 10:26 AM

@PCM_bio @WallStSai Wouldn't Kailera be in play before $VKTX? Hasn't the latter already proved to be inferior?

Open on X

@ftr_investorsOct 17, 2025 · 8:42 AM

Biggest Pre-Market Losers 👀🩸📉 $SLNH -28.4% $BITF -17.6% $QSI -16.5% $MVST -14.5% $CLSK -13.1% $JMIA -13.1% $NVTS -12.9% $HUT -11.7% $RGTI -11.6% $WYFI -10.9% $IREN -10.0% $SYM -9.8% $LAC -9.2% $APLD -9.2% $VKTX -9.0% $INOD -8.8% $CORZ -8.4% $ASTS -8.3% High-risk small caps in sectors like AI, & quantum computing are sliding fast. Is this bubble starting to burst? 💥

Open on X

@adamfeuersteinSep 22, 2025 · 12:26 PM

@lipa0902 @DrewQJoseph Because $PFE thought $MTSR has a better obesity pipeline than $VKTX? Pretty clear-cut answer.

Open on X

@adamfeuersteinAug 19, 2025 · 11:34 AM

$VKTX - Mizuho's Jared Holz on the oral data: Data look inferior to LLY on almost all metrics and the thing to consider here is that patients discontinued at such a high rate over 13-weeks vs. LLY in the mid 20% range but over 72-weeks. A much longer trial and therefor LLY looks far better head-to-head. This probably shutters hope for VKTX a bigtime player in the oral obesity market over the near to medium term. Pipeline and/or better versions needed to get investors and patients more interested. LLY could bounce a bit early but oral weight-loss programs continue to be highly controversial in terms of how they are perceived by the Street.

Open on X

@adamfeuersteinAug 19, 2025 · 11:22 AM

$LLY can now buy $VKTX much much cheaper. 🤷‍♀️

Open on X

@adamfeuersteinAug 19, 2025 · 11:12 AM

$VKTX oral obesity data reported https://t.co/Jpdl09DJ59

Open on X

$VKTX

$VKTX

About this stock

Related stocks

Frequently asked